Donald Landry

Donald Landry is a physician, organic chemist, and nephrologist known for his contributions to cardiovascular biology and cancer research.Landry’s scientific and medical innovations have been recognized through various awards, including the Presidential Citizens Medal in 2009 and his induction into the New Jersey Inventors Hall of Fame in 2016.

Landry is credited for the creation of an alternative method for stem cell extraction - using dead embryos rather than live ones - which became central to the George W. Bush Administration’s policy decisions on the topic. He is also known for identifying a vasopressin deficiency in vasodilatory shock, leading to the current clinical use of vasopressin to treat septic shock and vasodilatory shock. Additionally, he has created a variety of other advancements in medical treatment, introducing renal replacement therapy to treat kidney failure, and anti-cocaine antibodies.

Dr. Landry is a member of the American Chemical Society, the New York Academy of Sciences, the American Society for Clinical Investigation, the Association of American Physicians, the Practitioners Society of New York, and the American Society for Pharmacology and Experimental Therapeutics. He has published more than 160 articles in peer-reviewed journals, and holds over 20 patents. He is currently the chairman Department of Medicine at the Columbia University College of Physicians and Surgeons (P&S).

Education

Landry received his B.S. from Lafayette College, received his medical degree from Columbia University College of Physicians and Surgeons, and received his doctorate in organic chemistry from Harvard University. He completed residency in internal medicine at Massachusetts General Hospital and Harvard Medical School. He then trained in nephrology as an NIH Physician-Scientist.